The expression profiles of CXCL12, CXCR4 and CXCR7 in breast cancer biopsies are almost identical to that obtained when we overexpressed COUP-TFI in MCF-7 cancer cells, suggesting that our in-vitro results might have a clinical relevance. This evidence concerns the gene ACKR3 and breast cancer.